Growth Metrics

Standard Biotools (LAB) Gross Profit (2016 - 2026)

Standard Biotools has reported Gross Profit over the past 16 years, most recently at $11.4 million for Q4 2025.

  • Quarterly Gross Profit changed 0.22% to $11.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.2 million through Dec 2025, down 11.73% year-over-year, with the annual reading at $42.5 million for FY2025, 5.21% down from the prior year.
  • Gross Profit was $11.4 million for Q4 2025 at Standard Biotools, up from $9.5 million in the prior quarter.
  • Over five years, Gross Profit peaked at $30.7 million in Q1 2021 and troughed at $4.4 million in Q2 2022.
  • The 5-year median for Gross Profit is $12.1 million (2024), against an average of $15.6 million.
  • Year-over-year, Gross Profit plummeted 84.81% in 2022 and then surged 207.25% in 2023.
  • A 5-year view of Gross Profit shows it stood at $27.0 million in 2021, then crashed by 58.63% to $11.2 million in 2022, then rose by 19.61% to $13.4 million in 2023, then dropped by 14.97% to $11.4 million in 2024, then rose by 0.22% to $11.4 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Gross Profit are $11.4 million (Q4 2025), $9.5 million (Q3 2025), and $10.6 million (Q2 2025).